This session will provide an overview of various de novo methods, including standard, scaffold-, reaction-, and structure-based approaches. We will delve into their applications across different workflow challenges such as hit identification, hit-to-lead (H2L), and lead optimization.

Learn about the specific use cases for each de novo method and understand the unique benefits they offer in designing novel, drug-like, and synthetically viable compounds. This webinar is designed to equip medicinal chemists and drug discovery scientists with the knowledge to unlock new molecule design possibilities and accelerate their drug development journey.

Seize this chance to deepen your understanding of generative AI-driven drug discovery and explore how Aiddison software can augment your research methodologies.

Key Learnings

•  Understand De Novo Drug Design: Gain insights into different de novo methods, including scaffold-, reaction-, and structure-based. 
• Practical Applications: Explore how to apply de novo methods in hit identification, H2L, and lead optimization.
• Benefits & Advantages: Learn the unique benefits of each method for designing drug-like, synthetically viable compounds. 
• Who Should Attend: Ideal for medicinal chemists and drug discovery scientists seeking to accelerate drug development with cutting-edge AI tools.